Use of oxadiazaspiro compounds for use in the treatment of motoneuron degeneration or in neuroprotection

J.M. Vela; Xavier Navarro; Mireia Herrando Grabulosa; Manuel Merlós Roca

Use of oxadiazaspiro compounds for use in the treatment of motoneuron degeneration or in neuroprotection

J.M. Vela (Inventor/a), Xavier Navarro (Inventor/a), Mireia Herrando Grabulosa (Inventor/a), Manuel Merlós Roca (Inventor/a)

Departament de Biologia Cel·lular, de Fisiologia i d'Immunologia

Producció científica: Patent

Resum

The present invention relates to compounds having harmacological activity towards the sigma (#) receptor, and more particularly to oxadiazaspiro compounds having this pharmacological activity, for use in neuroprotection or in the treatment of motoneuron degeneration.

Idioma original	Anglès
Nombre de patent	EP21382845.2
IPC	A61K31/5386; A61P21/00; A61P25/28; C07D498/10
Estat de la publicació	Publicada - 20 de set. 2021

Altres arxius i enllaços

https://worldwide.espacenet.com/patent/search/family/077924327/publication/US2025002503A1?q=Use%20of%20oxadiazaspiro%20compounds

PAPEL DEL RECEPTOR SIGMA1 EN LA MODULACION DE LAS DISFUNCIONES DE LA MEMBRANA DEL RETICULO ENDOPLASMATICO ASOCIADA A MITOCONDRIA (MAM) EN LA DEGENERACION DE MOTONEURONAS
Navarro Acebes, X. (Investigador/a principal), Herrando Grabulosa, M. (Investigador/a), Badia Puiggali, C. (Col.laborador/a) & Gaja Capdevila, N. (Col.laborador/a)
Ministerio de Economía y Competitividad (MINECO), Fons Europeu de Desenvolupament Regional (FEDER)
1/01/19 → 30/09/22
Projecte: Projectes i Ajuts a la Recerca

Com citar-ho

@misc{ef4b7026e87f4b36aea5ad3269b78ee3,

title = "Use of oxadiazaspiro compounds for use in the treatment of motoneuron degeneration or in neuroprotection",

abstract = "The present invention relates to compounds having harmacological activity towards the sigma (\#) receptor, and more particularly to oxadiazaspiro compounds having this pharmacological activity, for use in neuroprotection or in the treatment of motoneuron degeneration.",

author = "J.M. Vela and Xavier Navarro and \{Herrando Grabulosa\}, Mireia and \{Merl{\'o}s Roca\}, Manuel",

year = "2021",

month = sep,

day = "20",

language = "English",

type = "Patent",

note = "EP21382845.2; A61K31/5386; A61P21/00; A61P25/28; C07D498/10",

}

TY - PAT

T1 - Use of oxadiazaspiro compounds for use in the treatment of motoneuron degeneration or in neuroprotection

AU - Vela, J.M.

AU - Navarro, Xavier

AU - Herrando Grabulosa, Mireia

AU - Merlós Roca, Manuel

PY - 2021/9/20

Y1 - 2021/9/20

N2 - The present invention relates to compounds having harmacological activity towards the sigma (#) receptor, and more particularly to oxadiazaspiro compounds having this pharmacological activity, for use in neuroprotection or in the treatment of motoneuron degeneration.

AB - The present invention relates to compounds having harmacological activity towards the sigma (#) receptor, and more particularly to oxadiazaspiro compounds having this pharmacological activity, for use in neuroprotection or in the treatment of motoneuron degeneration.

UR - https://worldwide.espacenet.com/patent/search/family/077924327/publication/US2025002503A1?q=Use%20of%20oxadiazaspiro%20compounds

M3 - Patent

M1 - EP21382845.2

ER -

Use of oxadiazaspiro compounds for use in the treatment of motoneuron degeneration or in neuroprotection

Resum

Altres arxius i enllaços

Fingerprint

Projectes

PAPEL DEL RECEPTOR SIGMA1 EN LA MODULACION DE LAS DISFUNCIONES DE LA MEMBRANA DEL RETICULO ENDOPLASMATICO ASOCIADA A MITOCONDRIA (MAM) EN LA DEGENERACION DE MOTONEURONAS

Com citar-ho